Top of this page
Skip navigation, go straight to the content

Heritage: the making of UCB

UCB was founded in 1928 and was originally a chemicals manufacturer with a separate pharmaceuticals division. By the 1950s the focus of UCB had shifted to prescription medicines.

In 2004, UCB acquired Celltech, the UK’s leading biotechnology company, which brought expertise in antibody-based drug discovery to the company. Schwarz Pharma was acquired in 2007, bringing its own portfolio of neurology and urology products.

UCB now focuses on severe diseases within immunology and CNS.

image description